Thermo Fisher Scientific Inc. (NYSE:TMO - Get Free Report) SVP Michael A. Boxer sold 2,000 shares of the stock in a transaction on Friday, April 26th. The shares were sold at an average price of $567.94, for a total transaction of $1,135,880.00. Following the completion of the sale, the senior vice president now owns 13,083 shares of the company's stock, valued at approximately $7,430,359.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Thermo Fisher Scientific Price Performance
Shares of NYSE:TMO opened at $576.87 on Tuesday. The company has a current ratio of 1.70, a quick ratio of 1.33 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $220.20 billion, a PE ratio of 37.00, a PEG ratio of 2.41 and a beta of 0.80. The firm has a 50 day moving average of $574.18 and a 200-day moving average of $531.06. Thermo Fisher Scientific Inc. has a 12 month low of $415.60 and a 12 month high of $603.82.
Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last released its earnings results on Wednesday, April 24th. The medical research company reported $5.11 earnings per share for the quarter, topping the consensus estimate of $4.70 by $0.41. Thermo Fisher Scientific had a return on equity of 18.45% and a net margin of 14.20%. The firm had revenue of $10.35 billion during the quarter, compared to analysts' expectations of $10.14 billion. On average, equities research analysts predict that Thermo Fisher Scientific Inc. will post 21.56 EPS for the current fiscal year.
Thermo Fisher Scientific Increases Dividend
The ONE AI Stock to own now. (It’s not Nvidia.)
From Weiss Ratings | Ad
Don’t panic — you haven’t missed the boat on AI.
In fact, it has barely launched.
Sure, the early stages of this boom were big …
But I believe the real wealth in AI has yet to be made …
Click here to see the presentation now.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 15th were issued a $0.39 dividend. This represents a $1.56 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date was Thursday, March 14th. This is a positive change from Thermo Fisher Scientific's previous quarterly dividend of $0.35. Thermo Fisher Scientific's dividend payout ratio (DPR) is 10.01%.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on TMO. HSBC raised their target price on shares of Thermo Fisher Scientific from $630.00 to $660.00 and gave the company a "buy" rating in a research note on Wednesday, April 17th. The Goldman Sachs Group boosted their target price on Thermo Fisher Scientific from $550.00 to $640.00 and gave the stock a "buy" rating in a report on Wednesday, April 10th. Barclays raised their price target on Thermo Fisher Scientific from $590.00 to $615.00 and gave the company an "equal weight" rating in a report on Thursday, April 25th. Sanford C. Bernstein reissued a "market perform" rating on shares of Thermo Fisher Scientific in a research report on Monday, January 8th. Finally, Royal Bank of Canada lifted their target price on shares of Thermo Fisher Scientific from $592.00 to $642.00 and gave the stock an "outperform" rating in a report on Thursday, February 1st. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Thermo Fisher Scientific presently has an average rating of "Moderate Buy" and a consensus price target of $606.76.
Check Out Our Latest Research Report on TMO
Hedge Funds Weigh In On Thermo Fisher Scientific
Large investors have recently modified their holdings of the business. WCM Investment Management LLC increased its stake in shares of Thermo Fisher Scientific by 0.3% in the fourth quarter. WCM Investment Management LLC now owns 989,837 shares of the medical research company's stock valued at $527,524,000 after buying an additional 2,928 shares during the period. Phoenix Holdings Ltd. raised its holdings in Thermo Fisher Scientific by 21.4% during the 3rd quarter. Phoenix Holdings Ltd. now owns 9,366 shares of the medical research company's stock worth $4,750,000 after purchasing an additional 1,654 shares during the last quarter. DMC Group LLC lifted its position in shares of Thermo Fisher Scientific by 16.5% in the 3rd quarter. DMC Group LLC now owns 592 shares of the medical research company's stock worth $300,000 after purchasing an additional 84 shares during the period. S. R. Schill & Associates increased its position in shares of Thermo Fisher Scientific by 106.3% during the fourth quarter. S. R. Schill & Associates now owns 1,537 shares of the medical research company's stock worth $816,000 after buying an additional 792 shares during the period. Finally, Check Capital Management Inc. CA acquired a new position in Thermo Fisher Scientific in the third quarter valued at $219,000. Institutional investors own 89.23% of the company's stock.
Thermo Fisher Scientific Company Profile
(
Get Free Report)
Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
